A friendly reminder

Community pharmacy teams have been reminded by the Pharmaceutical Services Negotiating Committee (PSNC) that since 1 April 2019 the drugs pregabalin and gabapentin have been reclassified as Schedule 3 controlled drugs (CDs). 

This means all gabapentin and pregabalin prescriptions will be subject to the prescription writing requirements for Schedule 3 CDs and it is now illegal to supply these drugs through repeat dispensing. However, pregabalin and gabapentin are included in the list of “exempted drugs” in the safe custody regulations, which means that they are not required to be kept in the CD cabinet.

Whilst Schedule 3 CDs are generally not yet prescribable via the electronic prescription service (EPS), some GP practices are piloting EPS CDs. Pharmacy teams should be aware that they may receive and dispense a mix of EPS and paper prescriptions, PSNC says.

NHS England has published a guidance document providing information on changes to the law relating to the reclassification of the drugs and a patient leaflet informing patients of the changes and how it will affect them. PSNC has also published an updated briefing on the reclassification. 

Recommended

APTUK responds to CPCF

Pharmacists among new group of diabetes clinical champions




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Training Matters's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.